Huorka M[Author] - Search Results

Year	Number of Results
1991	1
1993	2
1994	3
1995	5
1996	4
1997	4
1998	2
2000	2
2001	1
2002	1
2003	1
2005	1
2009	1
2010	1
2011	2
2012	2
2013	4
2014	4
2016	1
2018	2
2019	2
2021	1
2023	1
2024	0

1

Histamine Intolerance-The More We Know the Less We Know. A Review.

Hrubisko M, Danis R, Huorka M, Wawruch M. Hrubisko M, et al. Among authors: huorka m. Nutrients. 2021 Jun 29;13(7):2228. doi: 10.3390/nu13072228. Nutrients. 2021. PMID: 34209583 Free PMC article. Review.

2

[Hepatic injury.].

Labas P, Huorka M, Lukác L. Labas P, et al. Among authors: huorka m. Acta Chir Orthop Traumatol Cech. 1996;63(2):98-101. Acta Chir Orthop Traumatol Cech. 1996. PMID: 20470549 Slovak.

3

Pathophysiology and risk factors for cholelithiasis in patients with Crohn's disease.

Sturdik I, Krajcovicova A, Jalali Y, Adamcova M, Tkacik M, Sekac J, Koller T, Huorka M, Payer J, Hlavaty T. Sturdik I, et al. Among authors: huorka m. Physiol Res. 2019 Nov 30;68(Suppl 2):S173-S182. doi: 10.33549/physiolres.934302. Physiol Res. 2019. PMID: 31842581 Free article.

4

[Etiology and pathogenesis of acute pancreatitis].

al-Eryani S, Payer J, Huorka M, Duris I. al-Eryani S, et al. Among authors: huorka m. Bratisl Lek Listy. 1998 Jun;99(6):303-11. Bratisl Lek Listy. 1998. PMID: 9721465 Review. Slovak.

5

Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease.

Jalali Y, Gojdicova A, Sturdik I, Toth J, Koller T, Huorka M, Jalali M, Payer J, Hlavaty T. Jalali Y, et al. Among authors: huorka m. Bratisl Lek Listy. 2023;124(7):485-492. doi: 10.4149/BLL_2023_074. Bratisl Lek Listy. 2023. PMID: 37218475

6

[Therapy of acute pancreatitis].

al-Eryani S, Payer J, Huorka M, Duris I. al-Eryani S, et al. Among authors: huorka m. Bratisl Lek Listy. 1998 Jun;99(6):312-9. Bratisl Lek Listy. 1998. PMID: 9721466 Review. Slovak.

7

The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease.

Miznerova E, Hlavaty T, Koller T, Toth J, Holociova K, Huorka M, Killinger Z, Payer J. Miznerova E, et al. Among authors: huorka m. Bratisl Lek Listy. 2013;114(8):439-45. doi: 10.4149/bll_2013_092. Bratisl Lek Listy. 2013. PMID: 23944617

8

Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment.

Krajcovicova A, Batovsky M, Gregus M, Hlista M, Durina J, Leskova Z, Sturdik I, Gojdic M, Jalali Y, Koller T, Toth J, Huorka M, Hlavaty T. Krajcovicova A, et al. Among authors: huorka m. Acta Gastroenterol Belg. 2018 Oct-Dec;81(4):465-470. Acta Gastroenterol Belg. 2018. PMID: 30645913 Free article.

9

Impact of smoking cigarette on the mRNA expression of cytokines in mucosa of inflammatory bowel disease.

Vrablicova Z, Soltys K, Krajcovicova A, Stuchlikova K, Sturdik I, Koller T, Huorka M, Payer J, Killinger Z, Jackuliak P, Tkacik M, Stuchlik S, Sekac J, Hlavaty T. Vrablicova Z, et al. Among authors: huorka m. Physiol Res. 2019 Nov 30;68(Suppl 2):S183-S192. doi: 10.33549/physiolres.934301. Physiol Res. 2019. PMID: 31842582 Free article.

10

Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.

Desatova B, Hlavaty T, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Kadasi L, Huorka M, Batovsky M. Desatova B, et al. Among authors: huorka m. Bratisl Lek Listy. 2012;113(5):282-4. doi: 10.4149/bll_2012_065. Bratisl Lek Listy. 2012. PMID: 22616585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year